Depending on the dose administered, aspirin (and other NSAIDs) may produce opposing effects on the hemostatic mechanism. For example, platelet cyclooxygenase is inhibited by low-dose aspirin (60-325 mg/d), whereas larger doses (1.5-2 g/d) will also inhibit the production of prostacyclin (a potent vasodilator and platelet aggregation inhibitor) by vascular endothelial cells and thus result in a paradoxical thrombogenic effect. As a result, low-dose aspirin (81-325 mg/d) is theoretically a greater risk factor for bleeding than higher doses. Spontaneous and postoperative (unrelated to neuraxial technique) spinal hematomas have been reported with low-dose aspirin therapy.